Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Ando

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 17, 2013
Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative studyToshio Shinoda, Masahiro Yamasaki, Yoshiko Chida, et al.
Clinical and Experimental Nephrology|July 5, 2011
Nephrologist care for 12 months or more increases hemodialysis initiation with permanent vascular accessDaijo Inaguma, Ryoichi Ando, Masato Ikeda, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2005
The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolitesRyoichi Ando, Shotaro Naito, Yuichro Inagaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 8, 2020
COVID-19 of dialysis patients in Japan: Current status and guidance on preventive measures, , , et al.
Clinical and Experimental Nephrology|May 31, 2021
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilitiesYuka Sugawara, Masao Iwagami, Yoko Yoshida, et al.
Renal Replacement Therapy|October 26, 2021
Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort studyKan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, et al.
Renal Replacement Therapy|June 7, 2021
Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire surveyYuka Sugawara, Masao Iwagami, Kan Kikuchi, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patientsMasaki Ohya, Shigeo Negi, Toshifumi Sakaguchi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 17, 2013
Multicenter study of long-term (two-year) efficacy of lanthanum carbonateRyoichi Ando, Hitoshi Kimura, Hidehiko Sato, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2010
3-Cyano-6-(5-methyl-3-pyrazoloamino)pyridines: selective Aurora A kinase inhibitorsRyoichi Ando, Hiroshi Ikegami, Makoto Sakiyama, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 17, 2013
Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative studyToshio Shinoda, Masahiro Yamasaki, Yoshiko Chida, et al.
Clinical and Experimental Nephrology|July 5, 2011
Nephrologist care for 12 months or more increases hemodialysis initiation with permanent vascular accessDaijo Inaguma, Ryoichi Ando, Masato Ikeda, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2005
The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolitesRyoichi Ando, Shotaro Naito, Yuichro Inagaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 8, 2020
COVID-19 of dialysis patients in Japan: Current status and guidance on preventive measures, , , et al.
Clinical and Experimental Nephrology|May 31, 2021
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilitiesYuka Sugawara, Masao Iwagami, Yoko Yoshida, et al.
Renal Replacement Therapy|October 26, 2021
Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort studyKan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, et al.
Renal Replacement Therapy|June 7, 2021
Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire surveyYuka Sugawara, Masao Iwagami, Kan Kikuchi, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patientsMasaki Ohya, Shigeo Negi, Toshifumi Sakaguchi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 17, 2013
Multicenter study of long-term (two-year) efficacy of lanthanum carbonateRyoichi Ando, Hitoshi Kimura, Hidehiko Sato, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2010
3-Cyano-6-(5-methyl-3-pyrazoloamino)pyridines: selective Aurora A kinase inhibitorsRyoichi Ando, Hiroshi Ikegami, Makoto Sakiyama, et al.
Pageof 4